Nome |
# |
Serum zonulin in patients with inflammatory bowel disease: a pilot study, file e27ce42e-91b3-2581-e053-d805fe0acbaa
|
1.182
|
L'utilità clinica dell'Hepatitis B core-related antigen (HBcrAg), file e27ce42b-354a-2581-e053-d805fe0acbaa
|
988
|
Physiopathology of intestinal barrier and the role of zonulin, file e27ce42e-c4dd-2581-e053-d805fe0acbaa
|
905
|
Dual biological therapy with anti-TNF, vedolizumab or ustekinumab in inflammatory bowel disease: a systematic review with pool analysis, file e27ce42d-ffc9-2581-e053-d805fe0acbaa
|
731
|
Outcome of chronic delta hepatitis in Italy: a long-term cohort study., file e27ce426-c380-2581-e053-d805fe0acbaa
|
654
|
Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders., file e27ce42b-77d9-2581-e053-d805fe0acbaa
|
631
|
Risk of drug interactions and prescription appropriateness in elderly patients, file e27ce42e-d9db-2581-e053-d805fe0acbaa
|
610
|
Dupilumab to target interleukin 4 for inflammatory bowel disease? Hypothesis based on a translational message, file e27ce42e-c4db-2581-e053-d805fe0acbaa
|
580
|
Fecal calprotectin: beyond intestinal organic diseases, file e27ce42e-c975-2581-e053-d805fe0acbaa
|
461
|
Highly sensitive alpha-fetoprotein, Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin for hepatocellular carcinoma detection, file e27ce428-a516-2581-e053-d805fe0acbaa
|
382
|
Biochemical markers of bone metabolism during early orthodontic tooth movement with aligners, file e27ce42b-9b7e-2581-e053-d805fe0acbaa
|
380
|
Performance of protein induced by vitamin K absence or antagonist-II assessed by chemiluminescence enzyme immunoassay for hepatocellular carcinoma detection: a meta-analysis, file e27ce42e-8e39-2581-e053-d805fe0acbaa
|
376
|
Effectiveness and safety of adalimumab biosimilar ABP 501 in Crohn's disease: an observational study, file e27ce42f-4b41-2581-e053-d805fe0acbaa
|
372
|
Usefulness of the index of NASH – ION for the diagnosis of steatohepatitis in patients with Non-Alcoholic Fatty Liver: an external validation study, file e27ce42c-6c73-2581-e053-d805fe0acbaa
|
342
|
Hepatitis B Core-related Antigen Identify Patients With High Viral Load: Systematic Review and Meta-analysis of Individual Participant Data, file e27ce42f-e0c4-2581-e053-d805fe0acbaa
|
337
|
Glucose breath test and Crohn's disease: Diagnosis of small intestinal bacterial overgrowth and evaluation of therapeutic response, file e27ce42b-9ec6-2581-e053-d805fe0acbaa
|
327
|
Circulating Zonulin is Related to Hepatic Necroinflammation in Patients with Non Alcoholic Fatty Liver Disease, file e27ce42f-5aa2-2581-e053-d805fe0acbaa
|
313
|
Management of Helicobacter pylori in Piedmont, Italy, file e27ce42e-bfdc-2581-e053-d805fe0acbaa
|
300
|
Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers, file e27ce42f-2eb9-2581-e053-d805fe0acbaa
|
295
|
Hepatitis B core-related antigen kinetics in chronic hepatitis B virus genotype D-infected patients treated with nucleos(t)ide analogues or pegylated-interferon-α, file e27ce42b-ae29-2581-e053-d805fe0acbaa
|
282
|
Association of ITPA polymorphisms rs6051702/rs1127354 instead of rs7270101/rs1127354 as predictor of ribavirin-associated anemia in chronic hepatitis C treated patients., file e27ce42a-76ff-2581-e053-d805fe0acbaa
|
258
|
Chronic hepatitis B therapy: available drugs and treatment guidelines., file e27ce42b-9ec8-2581-e053-d805fe0acbaa
|
250
|
Adalimumab versus azathioprine to halt the progression of bowel damage in Crohn’s disease: application of Lémann Index, file e27ce42f-27c8-2581-e053-d805fe0acbaa
|
250
|
Diagnosis of Helicobacter pylori infection: a look into molecular aspects of urea breath test, file e27ce42e-7f46-2581-e053-d805fe0acbaa
|
247
|
Hepatitis B Core-Related Antigen: A Serum Biomarker for Intrahepatic Covalently-Closed-Circular DNA, file e27ce42e-a67c-2581-e053-d805fe0acbaa
|
240
|
Quantification of hepatitis B surface antigen with the novel DiaSorin LIAISON XL Murex HBsAg Quant: Correlation with the ARCHITECT quantitative assays., file e27ce42b-c67b-2581-e053-d805fe0acbaa
|
239
|
Strategies for Helicobacter pylori eradication in the year 2020, file e27ce42f-e9b8-2581-e053-d805fe0acbaa
|
238
|
Quantitation of HBV cccDNA in anti-HBc-positive liver donors by droplet digital PCR: A new tool to detect occult infection, file e27ce42d-2ee7-2581-e053-d805fe0acbaa
|
231
|
Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II, file e27ce42f-18ea-2581-e053-d805fe0acbaa
|
227
|
Incremental value of HBcrAg to classify 1582 HBeAg-negative individuals in chronic infection without liver disease or hepatitis, file e27ce431-a478-2581-e053-d805fe0acbaa
|
227
|
Clinical outcomes in chronic hepatitis C long-term responders to pre-direct antiviral agents: a single center retrospective study, file e27ce42e-18f4-2581-e053-d805fe0acbaa
|
218
|
LIVER DAMAGE CAN BE ASSOCIATED WITH DEREGULATION OF THE DE NOVO LIPOGENESIS PATHWAY IN SUBJECTS WITH NON ALCOHOLIC FATTY LIVER DISEASE, file e27ce428-ae68-2581-e053-d805fe0acbaa
|
181
|
AISF position paper on liver disease and pregnancy., file e27ce429-082c-2581-e053-d805fe0acbaa
|
165
|
Chronic HCV infection and lymphoproliferative disorders: mixed cryoglobulinemia syndrome, MGUS and B-cell non-Hodgkin lymphoma., file e27ce42a-6ef3-2581-e053-d805fe0acbaa
|
163
|
The adherence to the therapy in inflammatory bowel disease: beyond the number of the tablets, file e27ce42d-3314-2581-e053-d805fe0acbaa
|
160
|
IL28Bpolymorphism genotyping as predictor of rapid virologic response during interferon plus ribavirin treatment in hepatitis C virus genotype 1 patients, file e27ce427-0c0c-2581-e053-d805fe0acbaa
|
158
|
Microscopic colitis in patients with mild duodenal damage: A new clinical and pathological entity ("lymphocytic enterocolitis")?, file e27ce42a-d34c-2581-e053-d805fe0acbaa
|
146
|
Association Between Gut Permeability and Insulin Resistance: Any Role for Zonulin in Patients with Non-Alcoholic Fatty Liver Disease?, file e27ce431-38ec-2581-e053-d805fe0acbaa
|
142
|
Targeting IL-10, ZO-1 gene expression and IL-6/STAT-3 trans-signalling by a combination of atorvastatin and mesalazine to enhance anti-inflammatory effects and attenuate progression of oxazolone-induced colitis, file e27ce431-ffc7-2581-e053-d805fe0acbaa
|
142
|
HBV: GLI "END-POINTS" DELLA TERAPIA CON I NUCS + UPDATE 2016 SU NUOVE STRATEGIE TERAPEUTICHE DELL'INFEZIONE CRONICA HBV, file e27ce42a-68c3-2581-e053-d805fe0acbaa
|
139
|
Edaravone and MAPK pathway: the key role of gut permeability, file e27ce430-6637-2581-e053-d805fe0acbaa
|
136
|
CLINICAL EVALUATION OF CIRCULATING MICRORNAS AS POTENTIAL BIOMARKERS OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HBV INFECTION, file e27ce428-b118-2581-e053-d805fe0acbaa
|
123
|
Endocrine manifestations of chronic HCV infection, file e27ce42b-79f3-2581-e053-d805fe0acbaa
|
123
|
Serum Cytokeratin-18 Levels for Liver Fibrosis Prediction, file e27ce427-4c48-2581-e053-d805fe0acbaa
|
122
|
Basic and clinical aspects of resistin, file e27ce42e-afb7-2581-e053-d805fe0acbaa
|
121
|
Prediction of occult hepatitis B virus infection in liver transplant donors through hepatitis B virus blood markers., file e27ce429-f17c-2581-e053-d805fe0acbaa
|
119
|
The Usefulness of Microencapsulated Sodium Butyrate Add-On Therapy in Maintaining Remission in Patients with Ulcerative Colitis: A Prospective Observational Study, file e27ce430-db6b-2581-e053-d805fe0acbaa
|
112
|
Gastric emptying and related symptoms in patients treated with buspirone, amitriptyline or clebopride: a "real world" study by 13C-octanoic acid breath test, file e27ce42f-03ad-2581-e053-d805fe0acbaa
|
109
|
Laboratory evidence of Helicobacter species infection in hepatocellular carcinoma, file e27ce42d-1bf1-2581-e053-d805fe0acbaa
|
107
|
Liver fibrosis: the 2017 state of art, file e27ce42f-18e8-2581-e053-d805fe0acbaa
|
103
|
Increased serum ferritin levels predict long-term mortality in patients with NAFLD, file e27ce431-6b49-2581-e053-d805fe0acbaa
|
102
|
Epatocarcinoma: biomarcatori nella prevenzione, diagnosi e cura, file e27ce42a-f451-2581-e053-d805fe0acbaa
|
99
|
Helicobacter pylori, gastric cancer and gastric cancer stem cells, file e27ce42b-dc98-2581-e053-d805fe0acbaa
|
99
|
Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients, file e27ce42e-885a-2581-e053-d805fe0acbaa
|
97
|
Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with Bifidobacterium Longum ES1 for 8 or 12 Weeks: A Preliminary Report, file e27ce430-55fd-2581-e053-d805fe0acbaa
|
95
|
Re: El-Garem et al.: Seminal Helicobacter pylori Treatment Improves Sperm Motility in Infertile Asthenozoospermic Men (Urology 2014;84:1347-1350)., file e27ce428-a517-2581-e053-d805fe0acbaa
|
87
|
A Review of HDV Infection, file 45a4f9c4-447b-4a23-8372-63d95324c397
|
86
|
Utilizzo del test per la quantificazione dell’M2-PK fecale nell’ambito di un programma di screening per il carcinoma colorettale in soggetti positivi al FIT, file e27ce42d-7568-2581-e053-d805fe0acbaa
|
85
|
Hepatitis B Core-Related Antigen as Surrogate Biomarker of Intrahepatic Hepatitis B Virus Covalently-Closed-Circular DNA in Patients with Chronic Hepatitis B: A Meta-Analysis, file e27ce431-06a7-2581-e053-d805fe0acbaa
|
83
|
Incidence of Prostate Cancer in Inflammatory Bowel Disease: A Meta-Analysis, file e27ce430-0314-2581-e053-d805fe0acbaa
|
79
|
A Retrospective Experience of Helicobacter pylori Histology in a Large Sample of Subjects in Northern Italy, file e27ce432-79b6-2581-e053-d805fe0acbaa
|
77
|
On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases, file e27ce42f-7113-2581-e053-d805fe0acbaa
|
76
|
Role and function of exosomal miR-9-3p in hepatocellular carcinoma, file e27ce42f-108d-2581-e053-d805fe0acbaa
|
75
|
Treatment of hepatitis D, an unmet medical need, file e27ce430-7675-2581-e053-d805fe0acbaa
|
73
|
Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma, file e27ce430-7f9e-2581-e053-d805fe0acbaa
|
72
|
Cooperative role of thrombopoietin and vascular endothelial growth factor-a in the progression of liver cirrhosis to hepatocellular carcinoma, file e27ce431-e3da-2581-e053-d805fe0acbaa
|
71
|
Serum Interleukin-6 and -8 as Predictors of Response to Vedolizumab in Inflammatory Bowel Diseases, file e27ce42f-ea9c-2581-e053-d805fe0acbaa
|
65
|
The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review, file e27ce433-b51f-2581-e053-d805fe0acbaa
|
65
|
Switching from Biosimilar to Biosimilar Adalimumab, Including Multiple Switching, in Crohn's Disease: A Prospective Study, file e27ce432-4fcf-2581-e053-d805fe0acbaa
|
64
|
Inflammatory Bowel Disease Nurse—Practical Messages, file e27ce431-fc45-2581-e053-d805fe0acbaa
|
61
|
Analytical and clinical evaluation of a novel assay for anti-HBc IgG measurement in serum of subjects with overt and occult HBV infection, file e27ce42f-3175-2581-e053-d805fe0acbaa
|
60
|
Faecal miRNA profiles associated with age, sex, BMI, and lifestyle habits in healthy individuals, file e27ce433-1fb0-2581-e053-d805fe0acbaa
|
60
|
Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease, file e27ce434-2c8c-2581-e053-d805fe0acbaa
|
58
|
Hepatitis B core-related antigen: a novel biomarker for chronic hepatitis B treatment, file e27ce42b-9669-2581-e053-d805fe0acbaa
|
57
|
Interplay between Oxidative Stress and Metabolic Derangements in Non-Alcoholic Fatty Liver Disease: The Role of Selenoprotein P, file e27ce430-d1d5-2581-e053-d805fe0acbaa
|
56
|
The clinical role of serum epidermal growth factor receptor 3 in hepatitis c virus-infected patients with early hepatocellular carcinoma, file e27ce432-1f74-2581-e053-d805fe0acbaa
|
55
|
Biomarkers of oncogenesis, adipose tissue dysfunction and systemic inflammation for the detection of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease, file e27ce431-fcf2-2581-e053-d805fe0acbaa
|
54
|
Cytokines and biologic therapy in patients with inflammatory bowel diseases, file e27ce433-fae4-2581-e053-d805fe0acbaa
|
54
|
Role of serum hepatitis B core-related antigen in chronic hepatitis B infection, file e27ce42c-3d3c-2581-e053-d805fe0acbaa
|
53
|
The hepatitis D virus in Italy. A vanishing infection, not yet a vanished disease, file e27ce433-7ea9-2581-e053-d805fe0acbaa
|
51
|
Role of Circadian Clock on the Pathogenesis and Lifestyle Management in Non-Alcoholic Fatty Liver Disease, file 7bda2370-2c9d-46bb-89d4-8f71c9c9753b
|
50
|
Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease, file e27ce431-89fb-2581-e053-d805fe0acbaa
|
49
|
Plasma Selenoprotein P levels are related to adipose tissue insulin resistance, composition of free fatty acids and liver fibrosis in non-diabetic patients with Non Alcoholic Fatty Liver Disease, file e27ce42c-40be-2581-e053-d805fe0acbaa
|
48
|
Chronic hepatitis B treatmen: current perspectives on Telbivudine, file e27ce42c-92b0-2581-e053-d805fe0acbaa
|
48
|
Immunological and virological markers during pegylated interferon therapy in HDV chronic hepatitis: any predictor of response?, file e27ce430-46ab-2581-e053-d805fe0acbaa
|
47
|
Risk Factors of Urothelial Cancer in Inflammatory Bowel Disease, file e27ce432-4017-2581-e053-d805fe0acbaa
|
46
|
Treatment of hepatitis D, an unmet medical need, file e27ce42f-926c-2581-e053-d805fe0acbaa
|
45
|
Intestinal microbiota changes induced by TNF-inhibitors in IBD-related spondyloarthritis, file e27ce432-2f05-2581-e053-d805fe0acbaa
|
45
|
Serum cytokeratin-19 fragments (CYFRA 21-1) for the prediction of overall survival in patients with hepatocellular carcinoma, file e27ce430-72f2-2581-e053-d805fe0acbaa
|
44
|
Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease, file e27ce435-6c08-2581-e053-d805fe0acbaa
|
44
|
The combination of Index of NASH score and liver stiffness improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with NonAlcoholic Fatty Liver Disease., file e27ce42a-673d-2581-e053-d805fe0acbaa
|
43
|
Usefulness of a Hepatitis B Surface Antigen-Based Model for the Prediction of Functional Cure in Patients with Chronic Hepatitis B Virus Infection Treated with Nucleos(t)ide Analogues: A Real-World Study, file e27ce432-61f2-2581-e053-d805fe0acbaa
|
41
|
Shared microbiological and immunological patterns in periodontitis and IBD: A scoping review, file e27ce434-b132-2581-e053-d805fe0acbaa
|
41
|
On "diagnostic value of aberrant gene methylation in stool samples for colorectal cancer or adenomas", file e27ce42d-4382-2581-e053-d805fe0acbaa
|
40
|
Non-organ-specific autoimmunity in patients suffering from gastric ulcer with and without Helicobacter pylori infection, file e27ce42c-01c9-2581-e053-d805fe0acbaa
|
38
|
Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease, file e27ce434-49d4-2581-e053-d805fe0acbaa
|
37
|
CLINIC EVALUATION OF CIRCULATING MICRORNAS AS POTENTIAL BIOMARKERS OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH HBV CHRONIC INFECTION, file e27ce428-aba9-2581-e053-d805fe0acbaa
|
36
|
Hepatitis b virus reactivation upon immunosuppression: Is there a role for hepatitis b core-related antigen in patients with immune-escape mutants? a case report, file e27ce433-edc9-2581-e053-d805fe0acbaa
|
35
|
Insulin secretion and decreased glucose clearance are associated with enhanced fibrogenesis and a high risk of disease progression in non-diabetic patients with Non Alcoholic Fatty Liver Disease, file e27ce42b-e2aa-2581-e053-d805fe0acbaa
|
34
|
Efficacy of a preparation based on calcium butyrate, bifidobacterium bifidum, bifidobacterium lactis, and fructooligosaccharides in the prevention of relapse in ulcerative colitis: A prospective observational study, file e27ce433-719d-2581-e053-d805fe0acbaa
|
34
|
Totale |
18.658 |